Browse by Journal Title

Article

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na, I.K. and Buckland, M. and Agostini, C. and Edgar, J.D.M. and Friman, V. and Michallet, M. and Sánchez-Ramón, S. and Scheibenbogen, C. and Quinti, I.
European Journal of Haematology 102 (6): 447-456. June 2019

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Hemmati, P.G. and Vuong, L.G. and Terwey, T.H. and Jehn, C.F. and Le Coutre, P. and Penack, O. and Na, I.K. and Dörken, B. and Arnold, R.
European Journal of Haematology 98 (2): 160-168. February 2017

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.
Hemmati, P.G. and Terwey, T.H. and Na, I.K. and Jehn, C.F. and le Coutre, P. and Vuong, L.G. and Doerken, B. and Arnold, R.
European Journal of Haematology 95 (6): 498-506. December 2015

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate risk karyotype in first complete remission.
Hemmati, P.G. and Terwey, T.H. and Na, I.K. and le Coutre, P. and Jehn, C.F. and Vuong, L.G. and Dörken, B. and Arnold, R.
European Journal of Haematology 94 (5): 431-438. May 2015

R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.
Kreher, S. and Lammer, F. and Augustin, D. and Pezzutto, A. and Baldus, C.D.
European Journal of Haematology 93 (1): 70-76. July 2014

Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
Hemmati, P.G. and Schulze-Luckow, A. and Terwey, T.H. and le Coutre, P. and Vuong, L.G. and Doerken, B. and Arnold, R.
European Journal of Haematology 92 (2): 102-110. February 2014

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.
Hemmati, P.G. and Terwey, T.H. and le Coutre, P. and Vuong, L.G. and Massenkeil, G. and Doerken, B. and Arnold, R.
European Journal of Haematology 86 (4): 305-316. April 2011

BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.
le Coutre, P. and Reinke, P. and Neuhaus, R. and Trappe, R. and Ringel, F. and Lalancette, M. and Hemmati, P.G. and Doerken, B. and Daniel, P.T.
European Journal of Haematology 84 (1): 26-33. 1 January 2010

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf, M. and Hecht, K. and Reif, S. and Pelka-Fleischer, R. and Pfister, K. and Schmetzer, H.
European Journal of Haematology 72 (2): 89-106. February 2004

Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf, M. and Reif, S. and Hecht, K. and Pelka-Fleischer, R. and Pfister, K. and Nuessler, V. and Schmetzer, H.
European Journal of Haematology 71 (5): 366-376. November 2003